Indeed, the higher IFN‐γ is accompanied by more safety, efficacy (based on DAS‐28, and ACR indexes), reduction of inflammatory mediators, and recovery of RA patients from the disease.79 This evidence concerns the gene IFNG and rheumatoid arthritis.